ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of ContraFect Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. ContraFect Corp market cap is $1,100.00.
What is the 52-week high for ContraFect Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ContraFect Corp 52 week high is $0.14 as of October 09, 2025.
What is the 52-week low for ContraFect Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ContraFect Corp 52 week low is $0.00 as of October 09, 2025.
What is ContraFect Corp stock price today?
ContraFect Corp stock price today is $0.0001.
What was ContraFect Corp stock price yesterday?
ContraFect Corp stock price yesterday was $0.0001.
What is the 50-day moving average of ContraFect Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. ContraFect Corp 50-day moving average is $0.0004.